UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $194,950 | +17.3% | 11,618 | +4.9% | 0.00% | – |
| Q4 2023 | $166,200 | -93.3% | 11,080 | -92.5% | 0.00% | -100.0% |
| Q3 2021 | $2,497,000 | +1.9% | 148,439 | -7.5% | 0.01% | 0.0% |
| Q2 2021 | $2,451,000 | -24.4% | 160,521 | -3.5% | 0.01% | -28.6% |
| Q1 2021 | $3,240,000 | -48.3% | 166,352 | -52.2% | 0.01% | -46.2% |
| Q4 2020 | $6,268,000 | -14.2% | 347,867 | -8.2% | 0.01% | -18.8% |
| Q3 2020 | $7,309,000 | -3.1% | 378,871 | +31.1% | 0.02% | -11.1% |
| Q2 2020 | $7,546,000 | +125.7% | 288,889 | +54.1% | 0.02% | +100.0% |
| Q1 2020 | $3,343,000 | -16.5% | 187,419 | +56.1% | 0.01% | +12.5% |
| Q4 2019 | $4,005,000 | +1568.8% | 120,042 | +1694.6% | 0.01% | +700.0% |
| Q2 2019 | $240,000 | – | 6,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |